Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2005
10/26/2005CN1688548A Process for preparing quinolin antibiotic intermediates
10/26/2005CN1688534A Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising the
10/26/2005CN1688294A Enteric composition for the manufacture of soft capsule wall
10/26/2005CN1224630C Targetted polypeptide for specificity of liver cancer blood vessel
10/26/2005CN1224624C 1, 8-naphthyridin-2 (1H)-one derivatives
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224612C Acetylenic sulfonamide thiol TACE inhibitors
10/26/2005CN1224423C Pharmaceutical composition improved in peroral absorbability
10/26/2005CN1224415C Chinese herbal medicine as appendicitis resolving prepn
10/26/2005CN1224413C Chinese medicine granule preparation for curing stomatocace
10/26/2005CN1224411C Freeze-dried powder injection of Corydalis thalictrifolia franch for curing hepatitis, large dise transfusion medicine preparation method
10/26/2005CN1224408C Health-care capsule for improving function of stomach and intestine and preparing process thereof
10/26/2005CN1224402C Use of Euproctis pseudoconspersa in preparing medicine for treating diseases of gastrointestinal tract
10/26/2005CN1224390C Pharmaceutical composition comprising pyrroloquinoline quinone for curing and preventing fatty liver
10/26/2005CN1224387C Oral preparation of Tegaserod or its acid salt and its preparing process
10/25/2005US6958387 Human serpin polypeptides
10/25/2005US6958357 Central nervous system disorders; antiallergens; respiratory system disorders
10/25/2005US6958350 Chemical compounds
10/25/2005US6958349 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/25/2005US6958343 Treating psoriasis, a disease in which angiogenesis is associated with raised CXCR2 chemokine levels, or COPD.
10/25/2005US6958336 Anticancer agents; immunosuppressants; antiallergens; antiinflammatory agents
10/25/2005US6958332 Treating an interleukin-12 overproduction-related disorder; treating rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005US6958220 Inhibitors of proteasomal activity for stimulating hair growth
10/25/2005US6958159 Pharmaceutical gel composition
10/25/2005CA2359708C Ketolide antibiotics
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2005CA2266468C Preparation of 1-butyl-4-piperidinylmethylamine
10/23/2005CA2504796A1 Polymorphs of pantoprazole sodium salt and process for the preparation thereof
10/20/2005WO2005097988A1 Bone marrow-relevant cell participating the maintenance and/or repair of tissue
10/20/2005WO2005097976A1 Dendritic cell obtained by antigen pulsing
10/20/2005WO2005097972A1 Medium for lactic acid bacteria
10/20/2005WO2005097803A1 Novel water-soluble prodrug
10/20/2005WO2005097152A1 Turmeric extract-containing composition having improved caking capacity
10/20/2005WO2005097151A1 Antioxidant composition and products containing the same
10/20/2005WO2005097144A1 Composition for cleaning intestinal canal
10/20/2005WO2005097097A1 Agent for controlling cholesterol homeostasis-associated gene transcription activity mediated by fxr activation
10/20/2005WO2005096717A2 Agent exhibiting hepatoprotective properties
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050234248 Method of producing preparations rich in tocotrienol
10/20/2005US20050234245 Estrogen receptor modulators
10/20/2005US20050234129 Salts of nateglinide
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234117 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level
10/20/2005US20050234116 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia
10/20/2005US20050234090 Modulators of chemokine receptor activity
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234079 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy] benzyl]thiazolidine-2,4-dione potassium salt
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234051 5-Substituted 2-aryl-4 pyrimidinones
10/20/2005US20050234048 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
10/20/2005US20050234036 3-(2-tetrahydrofuryl-methyl)-2-thioxanthine; neuroinflammatory disorders; pain, cancers, rheumatic arthritis, neurodegenerative diseases
10/20/2005US20050234029 Compounds
10/20/2005US20050234022 Use of 2-alkoxyphenyl-substituted imidazotriazinones
10/20/2005US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233983 Treatment of rumen acidosis with alpha-amylase inhibitors
10/20/2005US20050233969 Analogues of GLP-1
10/20/2005US20050233956 Proteins involved in the regulation of energy homeostasis
10/20/2005US20050233447 A cell simultaneously expressing albumin protein and a membrane-associated CD14 surface antigen; expresses a mRNA sequence typical of hepatocytes selected from the group consisting of alpha-fetoprotein, carbamyl phosphate synthetase I, coagulation factor II, and coagulation factor VII
10/20/2005US20050233359 Isolated nucleic acid molecule encoding a neurotrophic growth factor
10/20/2005US20050232870 Method of treatment of dopamine-related dysfunction
10/20/2005CA2563502A1 Novel water-soluble prodrug
10/19/2005EP1586646A2 Lawsonia intracellularis vaccine
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586322A2 Compositions for inhibition of anglogenesis
10/19/2005EP1586312A1 Agent for dissolving dental calculi and dental caries
10/19/2005EP1585959A2 Extended glucagon-like peptide-1 analogs
10/19/2005EP1585956A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2005EP1585748A1 PYRAZOLO 3,4-d PYRIMIDINE DERIVATIVES AND THEIR USE I N THE TREATMENT OF H.PYLORI INFECTION
10/19/2005EP1585744A1 Process for making ondansetron and intermediates thereof
10/19/2005EP1585533A2 Composition of berry extracts that prevents or inhibits angiogenesis and helicobacter pylori
10/19/2005EP1585481A2 Pyrazolopyrimidine compound and process for preparing the same
10/19/2005EP1487272B1 Choline-silicic acid complex with osmolytes and divalent trace elements
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1423117B1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
10/19/2005EP1404656B9 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
10/19/2005EP1401837B1 Purine derivatives as a2b adenosine receptor antagonists
10/19/2005EP1397170B1 Safety shield system for prefilled syringes
10/19/2005EP1255740B1 Substituted arylpyrazines
10/19/2005EP1109570B1 Modulation of memory effector t-cells with a cd2 binding agent
10/19/2005EP1075260B1 Novel fatty acid analogues for the treatment of secondary restenosis
10/19/2005EP1073656B1 Imidazo pyridine derivatives which inhibit gastric acid secretion
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1684952A Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
10/19/2005CN1684705A Methods of use of compounds with preptin function
10/19/2005CN1684696A Oral and dental composition
10/19/2005CN1683551A Method for preparing cow fetus agent by composite enzyme method and its composite health product
10/19/2005CN1683369A S-omeprazole zinc salt and its preparing method and use
10/19/2005CN1683368A Simulated moving bed chromatography separating method of omeprazole antimer
10/19/2005CN1683367A Process for preparing lansoprazole sodium salt
1 ... 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 ... 1258